Fluoromount-G Anti-Fade

Produktübersicht

• Artikelname: Fluoromount-G Anti-Fade
• Artikelnummer: SBA-0100-35
• Hersteller Artikelnummer: 0100-35
• Alternativnummer: SBA-0100-35
• Hersteller: SouthernBiotech
• Kategorie: Biochemikalien
• Applikation: IHC, IHC, IHC, ICC

Produktbeschreibung

Fluoromount-G Anti-Fade

Zusatzinformationen

• Description: Fluoromount-G® Anti-Fade is a non-hardening, aqueous-based compound for mounting slides used in microscopy applications in which the preservation of fluorescence intensity is critical. This mounting medium provides a semi-permanent seal for storage of slide preparations and since Fluoromount-G® Anti-Fade is water-soluble, the coverslip may be removed by submerging the slide in a PBS solution until the coverslip is loosened.
• Buffer Formulation: Glycerol containing anti-fade components and other proprietary ingredients
• Volume: 20.0 mL
• Storage & Handling: Store at 2-8°C
  Please refer to product specific SDS
• Applications: Immunohistochemistry-Frozen Sections
  Immunohistochemistry-Paraffin Sections
  Immunocytochemistry
• Recommended Dilutions: Please refer to product specific

Bilder

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Goat Anti-Mouse IgA-UNLB (SB Cat. No. 1040-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-BIOT (SB Cat. No. 6164-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Paraffin embedded mouse small intestine tissue section was blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Rat Anti-Mouse IgA-UNLB (SB Cat. No. 1165-01) followed by Rabbit Anti-Rat IgG(H+L), Human ads-BIOT (SB Cat. No. 6185-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TRITC (SB Cat. No. 7100-03), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-TXRD (SB Cat. No. 7100-07), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-BIOT (SB Cat. No. 9400-08; right) followed by Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-FITC (SB Cat. No. 7100-02), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3 (SB Cat. No. 7100-12), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY3.5 (SB Cat. No. 7100-24), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Frozen newborn mouse cartilage sections were blocked with Normal Rabbit Serum (SB Cat. No. 0040-01) and stained with Mouse Anti-Collagen Type II-UNLB (right) followed by Rabbit F(ab')2 Anti-Mouse IgG(H+L), Human ads-BIOT (SB Cat. No. 6125-08), Streptavidin-CY2 (SB Cat. No. 7100-21), DAPI, and mounted with Fluoromount-G® Anti-Fade (SB Cat. No. 0100-35).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF488 (SB Cat. No. 1030-30).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-AF555 (SB Cat. No. 1030-32).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3.5 (SB Cat. No. 7100-24).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-BIOT (SB Cat. No. 1030-08) and Streptavidin-CY3 (SB Cat. No. 7100-12).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with DAPI.

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-FITC (SB Cat. No. 1030-02).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TXRD (SB Cat. No. 1030-07).

Human pancreatic carcinoma cell line MIA PaCa-2 was stained with Mouse Anti-Human CD44-UNLB (SB Cat. No. 9400-01) followed by Goat Anti-Mouse IgG, Human ads-TRITC (SB Cat. No. 1030-03).